In persons with melanoma, higher levels of Ruminococcaceae in the gut correlated with increased circulating effector CD4+ and CD8+ T cells and higher infiltrating antitumor immune cells, as well as a maintained cytokine response to anti-PD1 therapy. The gene discussed is PDCD1; the disease is melanoma.